RAPP
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. (RAPP) has 8 SEC Form 4 filings (14 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 15, 2026.
The most active filer is 10% Owner Third Rock Ventures V, L.P. with 5 filings. Insiders have net sold $36.3M over the trailing 6 months.
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$36.3M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$2.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 8,210 | $328K | Jul 15 | SEC ↗ | |
Gault CherylFirst filing | Chief Operating Officer | Sale | 10,000 | $416K | Jul 1 | SEC ↗ |
Ceesay AbrahamFirst filing | Chief Executive Officer | Sale | 8,220 | $327K | Jul 1 | SEC ↗ |
| 10% Owner | Sale | 18,572 | $744K | May 28 | SEC ↗ | |
| 10% Owner | Sale | 133,618 | $5.4M | May 13 | SEC ↗ | |
| 10% Owner | Sale | 271,495 | $10.9M | May 11 | SEC ↗ | |
| 10% Owner | Sale | 5,018 | $202K | May 11 | SEC ↗ | |
Yeleswaram KrishnaswamyFirst filing | Chief Development Officer | Sale | 20,225 | $809K | Apr 21 | SEC ↗ |
Third Rock Ventures V, L.P.First filing | 10% Owner | Sale | 426,005 | $17.2M | Apr 21 | SEC ↗ |
Related companies
Rapport Therapeutics, Inc. is in the Healthcare sector.